Innovation Fertility Preservation and IVF — An Honest Editorial Review

Among fertility clinics in New York, Innovation Fertility Preservation and IVF occupies a narrow but unusually deep niche: it was founded expressly around fertility preservation — oncofertility for cancer patients, elective egg freezing, and ovarian tissue cryopreservation — rather than as a general high-volume IVF program that later bolted on a preservation service line. The Manhattan practice is led by Dr. Kutluk "Lucas" Oktay, whose laboratory work on ovarian tissue freezing and transplantation has shaped the international field.

Dr. Oktay is board-certified in Obstetrics and Gynecology and in the Reproductive Endocrinology and Infertility (REI) subspecialty, and holds an academic appointment as Professor of Obstetrics, Gynecology and Reproductive Sciences at Yale University School of Medicine while continuing as Medical Director in New York. Patients come to Innovation Fertility primarily when a cancer diagnosis, a BRCA mutation, Turner syndrome, or another medical condition puts future fertility at risk, and when time-sensitive coordination with oncology is the priority.

Training and Credentials

Dr. Oktay completed his OB-GYN residency at the University of Connecticut Health Science Center in Farmington and his REI fellowship at the University of Texas Health Science Center at San Antonio, with an additional exchange fellowship in the Department of Reproductive Biology at the University of Leeds School of Medicine (UK). He also holds a PhD (Doctor of Health Sciences) from the University of Ghent in Belgium. He performed the world's first human ovarian transplantation procedures and described ovarian stimulation protocols designed for breast and endometrial cancer patients who cannot tolerate standard estrogen exposure. Browse his PubMed publications — a catalog of several hundred peer-reviewed papers spanning oncofertility, ovarian biology, and BRCA-related reproductive aging.

Services and Specialties

Services through Innovation Fertility Preservation and IVF include:

• In Vitro Fertilization (IVF), including conventional, minimal-stimulation, and random-start protocols
• Intrauterine Insemination (IUI) and ovulation induction
• egg freezing — elective and medically indicated
• donor egg IVF and third-party reproduction
• Preimplantation genetic testing (PGT-A / PGT-M)
• Ovarian tissue cryopreservation and autotransplantation
• Fertility preservation for cancer patients, BRCA mutation carriers, and transgender patients
• In vitro maturation (IVM) and care for young patients with Turner syndrome

Success Rates and Lab Quality

SART-member clinics report cycle outcomes annually; search the SART Clinic Summary Report and the CDC ART Success Rates database for the most current figures. Because Innovation Fertility's case mix skews heavily toward fertility-preservation cycles — often in younger oncology patients freezing eggs or embryos before chemotherapy — raw live-birth percentages are not directly comparable to general-infertility programs. Our how to read IVF success rates guide explains why age band, diagnosis, and cycle intent matter more than any headline number.

Patient Experience

Innovation Fertility's 5.0/17 Google rating reflects a smaller review base than a high-volume academic program, but the signal is consistent. Recurring themes point to rapid scheduling for time-sensitive oncofertility consults, detailed counseling on protocol choice (random-start vs. standard, letrozole-based stimulation for hormone-sensitive cancers), and close coordination with referring oncologists. The practice's niche focus means patients often arrive with complex medical histories that a general REI program might triage elsewhere.

Considering At-Home Insemination?

Not every fertility journey begins in a clinic. At-home intracervical insemination (ICI) is a lower-cost, private option that suits patients with no known fertility diagnosis — including single parents by choice, same-sex couples, and people who want to try a few cycles before committing to clinical treatment.

At-home insemination kits like those from MakeAMom come with step-by-step instructions designed for donor or partner sperm. Kits are a one-time purchase that can be reused until conception succeeds, require no clinic visit, and arrive in plain, discreet packaging. Many patients use them as a first step while working toward a fertility consultation — or alongside ovulation tracking while they wait for an appointment slot.

If you have a cancer diagnosis, a known fertility diagnosis, have been trying for 12 months without success (six months if you're over 35), or your physician has already recommended IUI or IVF, a board-certified reproductive endocrinologist is the right next step.

Insurance and Cost in New York

New York's 2020 fertility mandate requires large-group, state-regulated commercial plans to cover up to three IVF cycles and, importantly, includes fertility preservation for medically indicated patients — for example, before gonadotoxic cancer treatment. Self-funded (ERISA) employer plans are exempt from state mandates, and out-of-network oncofertility cycles are common; verify benefits before your first consult. See our fertility insurance mandates by state guide and IVF cost by state breakdown.

Location and Contact

Address: 245 5th Avenue, 3rd Floor, Suite 318, New York, NY 10016 Phone: (877) 492-3666 Website: fertilitypreservation.org

The practice also sees patients at a Midtown West location at 7 West 51st Street and at a Westchester office in Harrison, NY; confirm which site fits your care plan when scheduling.

Frequently Asked Questions

Is Innovation Fertility accepting new patients? Oncofertility referrals are typically prioritized because of the narrow window before chemotherapy or radiation. Call (877) 492-3666 to confirm current availability and routing between the Manhattan and Westchester offices.

Does Innovation Fertility accept insurance? The practice works with many commercial insurers. New York's 2020 mandate covers fertility preservation for medically indicated patients on most large-group plans; self-funded employer plans and cash-pay arrangements are handled case-by-case.

Is ovarian tissue freezing right for me? Ovarian tissue cryopreservation is now considered a non-experimental option by ASRM and is especially relevant when there is no time for a full ovarian-stimulation cycle before cancer treatment, or for pre-pubertal patients. Dr. Oktay pioneered the clinical protocol and can advise whether it fits your timeline.

Editorial note: Independently written by the Fertlo editorial team; not sponsored. See our editorial policy.